Advertisement
Screener

Coeptis Therapeutics, Inc. Proceeds from Royalties Received

Coeptis Therapeutics, Inc. Proceeds from Royalties Received

Coeptis Therapeutics, Inc. reported Proceeds from Royalties Received of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromRoyaltiesReceived · last filed 2021-11-15

  • Coeptis Therapeutics, Inc. proceeds from royalties received for the quarter ending 2021-09-30 was $0.00.
  • Coeptis Therapeutics, Inc. proceeds from royalties received for the quarter ending 2021-06-30 was $0.00.
  • Coeptis Therapeutics, Inc. proceeds from royalties received for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
  • Coeptis Therapeutics, Inc. proceeds from royalties received for the quarter ending 2020-09-30 was $0.00.
Period endProceeds from Royalties Received 3 monthProceeds from Royalties Received 6 monthProceeds from Royalties Received 9 month
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$0.00
derived: sum of 2 quarters · filed 2021-11-15
$0.00
10-Q · filed 2021-11-15
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16
$0.00
10-Q · filed 2021-08-16
2021-03-31$0.00
10-Q/A · filed 2021-05-18
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$0.00
derived: sum of 2 quarters · filed 2021-11-15
$250.00K
10-Q · filed 2021-11-15
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16
$250.00K
10-Q · filed 2021-08-16
2020-03-31$250.00K
10-Q/A · filed 2021-05-18